Neumoloxía
Servizo
University of British Columbia
Vancouver, CanadáPublicacións en colaboración con investigadores/as de University of British Columbia (9)
2023
-
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 7, pp. 1934-1948
-
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2732-2747
2022
-
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 5, pp. 1202-1216.e23
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2680-2688.e7
-
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
Chest
2020
-
International severe asthma registry (ISAR): Protocol for a global registry
BMC Medical Research Methodology, Vol. 20, Núm. 1
2019
-
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59